MEDFORD — EnEvolv, a biotechnology firm, will open a new and larger laboratory and research office in the city later this month. The 10,000-square-foot space on Boston Avenue will replace Envolv’s former facility on Morrissey Boulevard.
EnEvolv joins a cluster of other life sciences and technology companies including Greenlight Biosciences, Seventh Sense and MIDÉ at building operated by Cummings Properties.
EnEvolv works with pharmaceutical, nutrition, energy and specialty chemical companies to engineer microbes and produce bio-based chemicals. The company’s strain engineering platform combines biotechnology with automation to identify the changes in genomes that produce specific results, such as preventing genetically modified organisms from escaping and thriving in the wild.
“Boston Avenue in Medford is a great place for businesses to locate,” said Cummings leasing officer Steve Cusano, who worked on the transaction with Ellen Cullinan of Freudenheim Partners. “It’s close to research and academic institutions, public transportation, and many area amenities, and still offers free parking to employees and guests.”
“EnEvolv is expanding,” said Cullinan. “This new location offers the company flexibility to grow into an existing, first-class laboratory facility.”
